Hillengass et al evaluated whole body magnetic resonance imaging (MRI) as a means of evaluating a patient with asymptomatic multiple myeloma. They identified the presence of focal lesions in bone as a means to identify a patient who may benefit from more aggressive management. The authors are from University Hospital Heidelberg and the German Cancer Research Center.